Synthesis and dopamine transporter affinity of 2-(methoxycarbonyl)-9-methyl-3-phenyl-9-azabicyclo[3.3.1]nonane derivatives

Journal of Medicinal Chemistry

Volumn 39, Issue 24, 1996, Pages 4744-4749

  Chen, Zhengming ^a   Izenwasser, Sari ^b   Katz, Jonathan L ^b   Zhu, Naijue ^c   Klein, Cheryl L ^c   Trudell, Mark L ^a  

^a UNIVERSITY OF NEW ORLEANS   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2BETA (METHOXYCARBONYL) 9 METHYL 3BETA PHENYL 9 AZABICYCLO[3.3.1]NONANE; COCAINE; DOPAMINE RECEPTOR BLOCKING AGENT; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG ABUSE; DRUG CONFORMATION; DRUG DISTRIBUTION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ANIMALS; AZA COMPOUNDS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; CARRIER PROTEINS; COCAINE; CRYSTALLOGRAPHY, X-RAY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NERVE TISSUE PROTEINS; PROTEIN BINDING; RATS; RECEPTORS, DRUG;

EID: 0030449505     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960507d     Document Type: Article

References (38)

1. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr. Biochem. 1988, 7, 87-106.
2. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn-Schmeideberg's Arch. Pharmacol. 1985, 329, 227-235.
3. 3H]Cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 1989, 251, 131-141.
4. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237, 1219-1223.
5. Kuhar, M. J.; Ritz, M. C.; Boja, J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 1991, 14, 299-302.
6. Robinson, I.; Barridge, K. C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 1993, 18, 247-291.
7. Carroll, F. I.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J. Med. Chem. 1992, 35, 969-981.
8. Meltzer, P. C.; Liang, A. Y.; Brownell, A.-L.; Elmaleh, D. R.; Madras, B. K. Substituted 3-phenyltropane analogs of cocaine: Synthesis, inhibition of binding at cocaine recognition sites and position emission tomography imaging. J. Med. Chem. 1993, 36, 855-862.
9. Davies, H. M. L.; Saikali, E.; Huby, N. J. S.; Gilliatt, V. J.; Matasi, J. J.; Sexton, T.; Childers, S. R. Synthesis of 2β-acyl-3β-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J. Med. Chem. 1994, 37, 1262-1268.
10. Simoni, D.; Stoelwinder, J.; Kozikowski, A. P.; Johnson, K. M.; Bergmann, J. S.; Ball, R. G. Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: Discovery of a weak cocaine "antagonist". J. Med. Chem. 1993, 36, 3975-3977.
11. Kelkar, S. V.; Izenwasser, S.; Katz, J. L.; Klein, C. L.; Zhu, N.; Trudell, M. L. Synthesis, cocaine receptor affinity and dopamine uptake inhibition of several new 2β-substituted-3β-phenyltropanes. J. Med. Chem. 1994, 37, 3875-3877.
12. Carroll, F. I.; Kotian, P.; Dehghani, A.; Gray, J. L.; Kuzemko, M. A.; Parham, K. A.; Abraham, P.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues. New high affinity and selective compounds for the dopamine transporter. J. Med. Chem. 1995, 38, 379-388.
13. Kozikowski, A. P.; Saiah, M. K. E.; Johnson, K. M.; Bergmann, J. S. Chemistry and biology of the 2β-alkyl-3β-phenyl analogues of cocaine: Subnanomolar affinity ligands that suggest new pharmacophore model at the C-2 position. J. Med. Chem. 1995, 38, 3086-3093.
14. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol. 1984, 26, 35-44.
15. van der Zee, P.; Roger, H. S.; Gootjes, J.; Hespe, W. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 1980, 15, 363-370.
16. Meltzer, P. C.; Liang, A. Y.; Madras, B. K. The discovery of an unusually selective and novel cocaine analog: Difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. J. Med. Chem. 1994, 37, 2001-2010.
17. Newman, A. H.; Kline, R. H.; Allen, A. C.; Izenwasser, S.; George, C.; Katz, J. L. Novel 4′-substituted and 4′,4″-disubstituted-3α-(Diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors. J. Med. Chem. 1995, 38, 3933-3940.
18. Rothman, R. B. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development. Life Sci.-Pharmacol. Lett. 1990, 46, PL-17-PL-21.
19. Clarke, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cumiskey, W. R.; Bogado, E. F. Compounds affecting the central nervous system. 4. 3β-Phenyltropane-2-carboxylic esters and analogs. J. Med. Chem. 1973, 16, 1260-1267.
20. 2 receptors. J. Med. Chem. 1993, 36, 1488-1495.
21. 2 receptor with position emission tomography. J. Med. Chem. 1993, 36, 3707-3720.
22. Meshi, T.; Nakamura, S.; Sato, Y. Metabolic rate of 6,6,9-trimethyl-9-azabicyclo[3.3.1]non-3β-yl-α,α-di(2-thienyl) glycolate hydrochloride monohydrate. Chem. Pharm. Bull. 1972, 20, 1687-1698.
23. Rao, J.; Saxena, A. K. Studies on substituted-9-azabicyclo[3.3.1]-nonan-3-ones. Indian J. Chem. 1989, 28b, 620-625.
24. Menzies, R. C.; Robinson, R. A synthesis of ψ-pelletierine. J. Chem. Soc. 1924, 125, 2163-2168.
25. Cope, A. C.; Dryden, H. L.; Howell, C. F. Organic Syntheses, Coll. Vol. 4, Wiley and Sons, Inc.: New York, 1955; pp 816-819.
26. Lewin, A. H.; Naseree, T.; Carroll, F. I. A practical synthesis of (+)-cocaine. J. Heterocycl. Chem. 1987, 24, 19-21.
27. Carroll, F. I.; Coleman, M. L.; Lewin, A. H. Syntheses and conformational analyses of isomeric cocaines: A proton and carbon-13 nuclear magnetic resonance study. J. Org. Chem. 1982, 47, 13-19.
28. Carroll, F. I.; Lewin, A. H.; Abraham, P.; Parham, K.; Boja, J. W.; Kuhar, M. J. Synthesis and ligandbinding of cocaine isomers at the cocaine receptor. J. Med. Chem. 1991, 34, 883-886.
29. The authors have deposited atomic coordinates for compounds (+)-9·L-tartrate, 12 and 14 with the Cambridge Crystallographic Date Centre. The coordinates can be obtained, on request, from the Director, Cambridge Crystallographic Date Centre, 12 Union Rd, Cambridge, CB2 1EZ, U.K.
30. Stille, J. K.; Echavarren, A. M.; Williams, R. M.; Hendrix, J. A. 4-Methoxy-4′-nitrobiphenyl. Org. Synth. 1993, 71, 97-106.
31. Cacchi, S.; Morera, E.; Ortar. G. Palladium-catalyzed reduction of vinyl trifluoromethanesulfonates to alkenes: Cholestra-3,5-diene. Org. Synth. 1989, 68, 138-146.
32. Keverline, K. I.; Abraham, B.; Lewin, A. H.; Carroll, F. I. Synthesis of 2β,3α- and 2β,3β-isomers of 3-(p-substituted phenyl)-tropane-2-carboxylic acid methyl esters. Tetrahedron Lett. 1995, 36, 3099-3102.
33. Wustrow, D. J.; Wise, L. D. Coupling of aryl boronic acids with partially reduced pyridine derivatives. Synthesis 1991, 993-995.
34. Wiseman, J. R.; Krabbenhoft, M. O. Carbon-13 nuclear magnetic resonance spectroscopy in conformational analysis of 9-azabicyclo-[3.3.1]nonane derivatives. J. Org. Chem. 1975, 40, 3222-3224.
35. Wiseman, J. R.; Krabbenhoft, M. O. Carbon-13 nuclear magnetic resonance spectra of bridgehead substituted bicyclo[3.3.1]-nonanes. J. Org. Chem. 1977, 42, 2240-2244.
36. Barrelle, M.; Apparu, M.; Gey, C. Resonance magnétique nucleaire du carbone-13 de composes oxa- et azabicyclo[3.3.1]- et -[4.2.1]nonaniques. Can. J. Chem. 1978, 56, 85-92.
37. Arias, M. S.; Irecpa, I.; Galvez, E.; Lorente, A. Conformational study of N-substituted 9-azabicyclo[3.3.1]nonan-3-ones. J. Mol. Struct. 1989, 193, 161-172.
38. Izenwasser, S.; Terry, P.; Heller, B.; Witkin, J. M.; Katz, J. L. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. Eur. J. Pharm. 1994, 263, 277-283.